« Google Report Claims 67% Of All “Drive-By Downloads” Originate In China | Home | Apple in China, Part 1: Apple Takes An Unfair Beating On iPhone »
Baxter Blood-Thinner Case: Who Didn’t Check What?
By Paul Midler | February 17, 2008
A few newspapers have reported on the contaminated blood-thinner news by leading with the information that the facilities had not been inspected by the FDA. I’m going to leave alone the issue of facility inspections and instead reference an e-mail that I received from an old friend who happens to be in corporate finance as a specialist in parmaceuticals. He says that some suspect it may not have been the active pharmaceutical ingredient (API), but the vials instead. He says that Baxter had a problem with vials about two years back. If this is true, I can’t understand why news outlets that are defensive of China have not reported on this one aspect of the investigation.
Topics: China |
February 17th, 2008 at 11:29 pm
Wanted to throw out a general comment. Thanks to those who commented on posts below. If anyone has a suggestion for a post at this website, please feel free to email me directly…
February 20th, 2008 at 12:15 pm
Perhaps it is the news outlet’s desire to blame someone else OTHER than China for once. As well, it is also because there is the hooplah that this Chinese manufacturer should never have been making this stuff in the first place that leads ppl to question the US FDA’s supervisory methods. (10-20 plant inspections per year of over 700 in China really doesn’t amount to much, which I argued in my blog–but I blame all parties, not just the FDA)